Morphological assessment of neointimal tissue using optical coherence tomography (OCT) is important for clarifying the pathophysiology of in-stent restenosis (ISR) lesions. The aim of this study was to determine the impact of OCT findings on recurrence of ISR after various types of percutaneous coronary intervention (PCI) including plain old balloon angioplasty (POBA), paclitaxel-coated balloon (PCB) dilatation, and drug-eluting stent (DES) implantation.
Introduction
Morphological assessment of neointimal tissue using optical coherence tomography (OCT) is important for clarifying the pathophysiology of in-stent restenosis (ISR) lesions. 1 The response to various types of percutaneous coronary intervention (PCI) might vary according to the pathophysiology of ISR lesions, and OCT findings may be related to recurrence of ISR. Recently, we reported that ISR and target lesion revascularization (TLR) rates in ISR lesions with a homogeneous structure, high backscatter, and non-lipid-rich intima treated with a paclitaxel-coated balloon (PCB) were significantly lower than those in ISR lesions treated with plain old balloon angioplasty (POBA). 2 However, it is not known whether there is a difference in the effectiveness of a drug-eluting stent according to tissue characterization assessed with OCT compared with PCB and POBA. The aim of this study was therefore to determine the impact of OCT findings on recurrence of ISR after various types of PCI including POBA, PCB, and DES.
Methods

Patients and lesions
Between June 2008 and August 2013, we performed PCI for 468 ISR lesions in 415 patients using POBA only (83 lesions), POBA + PCB (226 lesions), or POBA + DES (159 lesions) with assessment by OCT. Morphological assessment by OCT of neointimal tissue at the minimum lumen area site, including restenotic tissue structure (homogeneous, heterogeneous, or layered type) and restenotic tissue backscatter (high or low), was performed. Follow-up angiography at 6 -8 months after PCI was performed in 428 ISR lesions (follow-up rate: 91.5%) in 379 patients treated with POBA only (POBA group: 78 lesions), POBA + PCB (PCB group: 202 lesions), or POBA + DES (DES group: 148 lesions). We examined the associations between tissue morphology and mid-term (6 -8 months) results including ISR and TLR rates. The study schema is shown in Figure 1 . The risks of PCI and follow-up CAG were explained to each patient, and written informed consent was obtained from all patients.
Procedures for PCI and OCT
Procedures for PCI and OCT were previously reported. 2 Cardiac catheterization was performed using a 6 or 7-F sheath and guiding catheter via the trans-radial or brachial approach. Intravenous heparin ( 100 U/kg adjusted depending on age) and intra-coronary nitrates were administered at the beginning of the procedure. After initial angiography of the target vessel, OCT was performed to obtain information on the entire target vessel. Pre-dilatation using a coronary balloon with a small diameter (1.5-2.25 mm) was performed before OCT when the target lesions were too tight to allow the OCT catheter to pass through. Between July 2008 and September 2011, time-domain OCT was performed using a 0.016-inch OCT catheter (ImageWire; Light Lab Imaging, USA). The OCT catheter was advanced to the distal end of the stent through a 3-F occlusion balloon catheter. To remove blood from the field of view, the occlusion balloon was inflated up to 0.6 atm at a proximal site of the lesion, and warm lactated Ringer's solution was infused into the coronary artery from the distal tip of the occlusion balloon catheter at 0.7 mL/s. Between October 2011 and August Figure 1 The schema of this study. PCI indicates percutaneous coronary intervention; ISR, in-stent restenosis; OCT, optical coherence tomography; MLA, minimum lumen area; CAG, coronary angiography; PCB, paclitaxel-coated balloon; POBA, plain old balloon dilatation; DES, drug-eluting stent; TLR, target lesion revascularization.
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2013, frequency-domain OCT was performed using a monorail-type OCT imaging catheter (Dragonfly; St Jude Medical, USA). The OCT catheter was advanced to the distal end of the stent along a 0.014-inch coronary guide wire. To remove blood from the field of view, a contrast agent was infused. The entire lesion length was imaged with an auto-pullback, and the OCT image clearly visualized the target vessel. After all recordings, PCI was performed for all lesions. First, all lesions were dilated with either a high-pressure balloon or scoring balloon or with both balloons. In the POBA group, the procedure was completed at that time. In the PCB group, further balloon dilatation using a paclitaxel-coated PTCA balloon (SeQuent Please balloon catheter; B. Braun Melsungen AG, Vascular Systems, Berlin, Germany) was performed. The recommended inflation time for the PCB was 60 s, and inflation pressure was rated burst pressure (14 atm). In the DES group, further DES implantation and post-dilatation with a high-pressure balloon were performed. The types of DES using in this study were as follows: sirolimus-eluting stent in 24 lesions, paclitaxel-eluting stent in 20 lesions, zotarolimus-eluting stent in 8 lesions, cobalt-chrome everolimus-eluting stent in 64 lesions, platinum-chrome everolimus-eluting stent in 14 lesions, and biolimuseluting stent in 18 lesions. This was a retrospective study, and there was no clear criterion for choosing the treatment strategy (POBA, PCB, or DES) and it depended on operators' choice. Generally, we added stent implantation when we could not obtain a good angiographic result after pre-dilatation with high-pressure balloon.
Image analysis of CAG and OCT
Image analysis of CAG and OCT was previously reported. 2 Quantitative coronary angiographic analysis (QCA) was performed with an automatic edge-detection system (MEDIS, QCA-CMS ver.6, Netherlands). The analysis was performed through the in-stent segment and the adjacent proximal and distal 5-mm vessel segment. Quantitative measurements included reference vessel diameter, minimal luminal diameter, percentage diameter stenosis, and lesion length. Derived variables included acute gain ¼ post-procedural minimum lumen diameter 2 pre-procedural minimum lumen diameter, and late loss ¼ postprocedural minimum lumen diameter 2 follow-up minimum lumen diameter. The OCT data were stored digitally and analysed by an OCT imaging system (Light Lab Imaging, USA) and an ILUMIEN OCT imaging system (St Jude Medical, USA). Quantitative analyses of OCT images were performed at minimum lumen area site. The minimum lumen area and stent area were manually traced, and the neointimal area and neointimal thickness were automatically calculated. Qualitative analyses of OCT images were performed at the minimum lumen area site by two experienced physicians who were blinded to clinical and angiographic lesion characteristics. 3 -5 When the two physicians had difference opinions, they reached a final decision after discussion. To assess inter-observer variability in diagnosis of OCT findings including restenotic tissue structure and restenotic tissue backscatter, OCT images were analysed independently by two experienced interventional cardiologists who were blinded to the clinical data. Furthermore, one of the two observers evaluated all OCT images again at 4 months after initial evaluation to assess intra-observer variability in diagnosis of OCT findings including restenotic tissue structure and restenotic tissue backscatter.
Definition of OCT findings of restenotic tissue structure and restenotic tissue backscatter Figure 2 .
Clinical and angiographic follow-up after PCI
Clinical and angiographic follow-up was performed at 6 months after a successful procedure in the POBA and PCB groups and at 8 months in the DES group. A follow-up angiogram was obtained earlier if clinically indicated. Binary restenosis at follow-up was defined as stenosis occupying .50% of the diameter. TLR was defined as any repeat PCI or coronary bypass surgery due to restenosis (percentage diameter stenosis ≥50%) associated with symptoms or objective signs of ischaemia.
Statistical analysis
The data are expressed as means + SD. Inter-group comparison was done by the x 2 independence test or Fisher's exact probability test, and difference in mean values was tested by Student's t-test, at a critical level of 5% or lower. Comparison of continuous variables between the three groups was done by ANOVA. Multiple lesions within the same patient were assumed to be independent of each other. To assess the independent predictors of the occurrence of re-ISR, multivariable logistic regression analysis was performed for lesions with homogeneous structure and those with high backscatter. Inter-and intra-observer variabilities in diagnosis of tissue morphology were evaluated by Cohen's coefficient kappa. All data were analysed using SPSS software (version 11.0.1).
Results
Baseline patient and lesion characteristics
The patients included 308 men and 71 women with a mean age of 68.9 + 9.4 years. The mean follow-up period was 211 + 40 days. Patient and lesion characteristics in the three groups are shown in Tables 1 and 2 . There were no differences in patient and lesion characteristics between the three groups other than co-morbid rate of diabetes mellitus, follow-up duration, and previous stent type.
Differences in mid-term results between the PCB, POBA and DES groups in all lesions
In all lesions, the mid-term results including ISR and TLR rates in each group are shown in Figure 3 . ISR rate in the POBA group was significantly higher than that in the PCB group (44.9 vs. 22.8%, P , 0.001) and that in the DES group (44.9 vs. 17.6%, P , 0.001). TLR rate in the POBA group was also significantly higher than that in the PCB group (33.3 vs. 16.8%, P ¼ 0.004) and that in the DES group (33.3 vs. 12.8%, P , 0.001). There were no differences in ISR and TLR rates between the PCB and DES groups.
Association between tissue characteristics and mid-term results
Tissue characteristics assessed by OCT in the PCB, POBA, and DES groups
Representative cases with OCT images for OCT characteristics are shown in Figure 2 . In OCT analysis, there was no difference in the distribution of restenotic tissue structure type or restenotic tissue backscatter type between three groups ( Table 3) .
Associations between restenotic tissue structure and acute and mid-term results
The associations between restenotic tissue structure and acute/ mid-term results are shown in Figures 4 and 5 . Acute gain of lesions with a homogeneous and layered structure was significantly larger in the DES group than in the POBA and PCB Figure 3 Mid-term results including ISR and TLR rates of each group in all lesions. ISR and TLR rates in the POBA group were significantly higher than those in the PCB group and DES group. There was no difference in ISR and TLR rates between the PCB and POBA groups. ISR, in-stent restenosis; TLR, target lesion revascularization; POBA, plain old balloon dilatation; PCB, paclitaxel-coated balloon; DES, drug-eluting stent.
Association between tissue characteristics and mid-term results Figure 4 Associations between restenotic tissue structure and acute/mid-term results. Acute gains of lesions with homogeneous and layered structures were significantly larger in the DES group than in the POBA and PCB groups. There was no difference in acute gain of lesions with a heterogeneous structure between the three groups (A). Late losses of lesions with homogeneous and layered structures were significantly lower in the PCB group than in the POBA and DES groups. There was no difference in late loss of lesions with a heterogeneous structure between the three groups (B). POBA, plain old balloon dilatation; PCB, paclitaxel-coated balloon; DES, drug-eluting stent.
groups (DES vs. POBA: 1.53 + 0.60 vs. 1.00 + 0.59 mm, P , 0.001; DES vs. PCB: 1.53 + 0.60 vs. 1.21 + 0.52 mm, P ¼ 0.001). Acute gain of lesions with a layered structure was also significantly larger in the DES group than in the POBA and PCB groups (DES vs. POBA: 1.58 + 0.63 vs. 1.14 + 0.63 mm, P ¼ 0.001; DES vs. PCB: 1.58 + 0.63 vs. 1.19 + 0.57 mm, P , 0.001). There was no difference in acute gain of lesions with a heterogeneous structure between the three groups. Late loss of lesions with a homogeneous structure was significantly lower in the PCB group than in the POBA and DES groups (PCB vs. POBA: 0.24 + 0.57 vs. 0.70 + 0.64 mm, P , 0.001; PCB vs. DES: 0.24 + 0.57 vs. 0.52 + 0.65 mm, P ¼ 0.005). Late loss of lesions with a layered structure was also significantly lower in the PCB group than in the POBA and DES groups (PCB vs. POBA: 0.24 + 0.57 vs. 0.70 + 0.64 mm, P , 0.001; PCB vs. DES: 0.24 + 0.57 vs. 0.52 + 0.65 mm, P ¼ 0.005). There was no difference in late loss of lesions with a heterogeneous structure between the three groups.
ISR rate of lesions with a homogeneous structure was significantly higher in the POBA group than in the PCB and DES groups (POBA vs. PCB: 54.8 vs. 19.1%, P , 0.001; POBA vs. DES: 54.8 vs. 19.6%, P ¼ 0.002). ISR rate of lesions with a layered structure was also significantly higher in the POBA group than in the PCB and DES groups (POBA vs. PCB: 43.2 vs. 22.0%, P ¼ 0.027; POBA vs. DES: 54.8 vs. 15.8%, P ¼ 0.002). There was no difference in ISR rate of lesions with a heterogeneous structure between the three groups.
TLR rate of lesions with a homogeneous structure was significantly higher in the POBA group than in the PCB and DES groups (POBA vs. PCB: 38.7 vs. 10.6%, P , 0.001; POBA vs. DES: 38.7 vs. 10.7%, P ¼ 0.005). TLR rate of lesions with a layered structure was significantly higher in the POBA group than in the DES group (POBA vs. DES: 32.4 vs. 13.2%, P ¼ 0.022). There was no difference in TLR rate of lesions with a heterogeneous structure between the three groups.
To assess the independent predictors of the occurrence of re-ISR in 181 lesions with homogeneous structure, multivariable logistic regression analysis was performed ( Table 4) . Multivariable analysis showed that PCI with POBA was independently associated with occurrence of re-ISR (odds ratio 5.14, 95% confidence interval 2.24 -11.80, P , 0.001).
Figure 5
Associations between restenotic tissue structure and mid-term results. ISR rates of lesions with homogeneous and layered structures were significantly higher in the POBA group than in the PCB and DES groups. There was no difference in ISR rate with a heterogeneous structure between three groups (A). TLR rate of lesions with a homogeneous structure was significantly higher in the POBA group than in the PCB and DES groups. TLR rate of lesions with a layered structure was significantly higher in the POBA group than in the DES group. There was no difference in TLR rate of lesions with a heterogeneous structure between the three groups (B). ISR, in-stent restenosis; TLR, target lesion revascularization; POBA, plain old balloon dilatation; PCB, paclitaxel-coated balloon; DES, drug-eluting stent.
Association between tissue characteristics and mid-term results
Associations between restenotic tissue backscatter and acute and mid-term results
The associations between restenotic tissue backscatter and acute/ mid-term results are shown in Figures 6 and 7 .
Acute gain of lesions with a high backscatter was significantly larger in the DES group than in the POBA and PCB groups (DES vs. POBA: 1.50 + 0.56 vs. 1.02 + 0.59 mm, P , 0.001; DES vs. PCB: 1.50 + 0.56 vs. 1.17 + 0.49 mm, P , 0.001). Acute gain of lesions with a low backscatter was also significantly larger in the DES group than in the POBA and PCB groups (DES vs. POBA: 1.55 + 0.69 vs. ISR rate of lesions with a high backscatter was significantly higher in the POBA group than in the PCB and DES groups (POBA vs. PCB: 51.1 vs. 19.8%, P , 0.001; POBAvs. DES: 51.1 vs. 18.8%, P , 0.001). ISR rate of lesions with a low backscatter was significantly higher in the POBA group than in the DES group (36.4 vs. 16.2%, P ¼ 0.041).
TLR rate of lesions with a high backscatter was significantly higher in the POBA group than in the PCB and DES groups (POBA vs. PCB: 40.0 vs. 11.9%, P , 0.001; POBA vs. DES: 40.0 vs. 11.3%, P , 0.001). There was no difference in TLR rate of lesions with a low backscatter between the three groups.
To assess the independent predictors of the occurrence of re-ISR in 251 lesions with high backscatter, multivariable logistic regression analysis was performed ( Table 5 ). Multivariable analysis showed that PCI with POBA was independently associated with occurrence of re-ISR (odds ratio 4.70, 95% confidence interval 2.34-9.43, P , 0.001).
Reproducibility of results of OCT analysis
Inter-and intra-observer variabilities (k values) in qualitative OCT assessment were 0.93/0.91 for restenotic tissue structure and 0.91/0.89 for restenotic tissue backscatter.
Discussion
This is the first study on the association between tissue morphologies of ISR intima evaluated by OCT and mid-term results including late loss, ISR rate, and TLR rate after DES implantation. It was recently reported that ISR lesions with a homogeneous structure, high backscatter, and non-lipid-rich intima were favourable for PCB dilatation compared with POBA. 2 The main finding of our study is that ISR and TLR rates for each tissue morphology after DES implantation were similar to those after PCB dilatation. Furthermore, in lesions with homogenous structure and in those with high backscatter, PCI with POBA for ISR lesions was an independent predictor of re-ISR. In lesions with a homogeneous structure, layered structure, and high backscatter, good mid-term outcomes after DES implantation could be due to larger acute gain compared with POBA, while good mid-term outcomes of PCB dilatation in lesions with those structures could be due to smaller late loss compared with POBA. Thus, it appears reasonable to decide to implant DES if sufficient MLD cannot be obtained after pre-dilatation with a high-pressure balloon in such morphologies. The results of a previous study suggested that lesions with a homogeneous structure and high backscatter have high proliferative activity of vascular smooth muscle cells and that treatment using a PCB after pre-dilatation with a high-pressure balloon is preferable for such lesions. 2 The same could be said for DES compared with POBA. In a previous study, it was shown that PCB might also have a beneficial effect on lesions with layered neointima compared with POBA, but there was no significant difference in ISR (22.5 vs. 39.4%, P ¼ 0.100) and TLR (19.7 vs. 36.4%, P ¼ 0.0.89) rates between two groups. In this study, we observed that there was a significant difference in ISR rates between PCB and POBA groups (22.0 vs. 43.2%, P ¼ 0.027). The increase of number of cases might be one of the reasons for the discrepancy between the two studies. In this study, there was also a significant difference in ISR rate of lesions with layered neointima between DES and POBA groups (15.8 vs. 43.2%, P ¼ 0.002). As described previously, from OCT findings in our study, many of the lesions with a layered structure consisted of homogeneous inner layer with high backscatter and low backscattered outer layer with attenuation. Such lesions might include a certain amount of vascular smooth muscle cells in their inner layer. PCB and DES might therefore be effective for such type of layered neointima, because the drugs could inhibit vascular smooth muscle cell proliferation. However, in this study, there was no difference in TLR rate between PCB and POBA group (18.3 vs. 32.4%, P ¼ 0.102), and this result was consistent with the previous study. Further accumulation of cases is needed. There was no difference in acute gain, late loss, ISR rate, or TLR rate in lesions with a heterogeneous structure between the three groups. There was also no difference in TLR rate in lesions with low backscatter between the three groups. Although the histopathology of a heterogeneous structure has remained unclear, it was speculated that lesions with a heterogeneous structure and low backscatter consisted of hypocellular tissues and contained a high proportion of myxomatous extracelluar matrix like proteoglycans and organizing fibrin thrombus. 6 It was also reported that excessive inflammation, fibrin accumulation, organized thrombus, and in-stent atherosclerosis were similarly shown as a dark appearance without a clear border on OCT in comparison with autopsy data. 7 In our study, a previous BMS was used in only two cases of lesions with a heterogeneous structure (2cases/52cases, 3.8%, data not shown). These results suggested that inflammation due to hypersensitivity reaction to drugs and/or polymers of a DES might play an important role in the mechanism of heterogeneous neointimal regrowth. 7 -9 In such lesions with a heterogeneous structure, repetitive use of a DES or additional use of a PCB might aggravate inflammation and might not be effective against recurrence of ISR. It has been reported that drug-eluting stent restenosis was associated with poorer outcomes than was BMS-ISR after treatment with a PCB. 10 -12 This result might be associated with our findings of insufficient effects of a DES and PCB in lesions with a heterogeneous structure.
Limitations
There are several limitations in this study, and they were the same limitations as those previously reported. 2 First, this was a retrospective study, and there might be selection bias of the lesions. Because this was a retrospective study, there were some differences in baseline patient characteristics between the three treatment groups such as diabetes mellitus and previous stent type. Diabetes mellitus is a well-known risk factor for ISR, and it was reported that outcomes after DES implantation or PCB dilatation were worse in patients with DES-ISR than in those with BMS-ISR. 10 -12 Thus, we should take into account the impact of the difference in baseline patient Figure 6 Associations between restenotic tissue backscatter and acute/mid-term results. Acute gains of lesions with high and low backscatters were significantly larger in the DES group than in the POBA and PCB groups (A). Late loss of lesions with a high backscatter was significantly smaller in the PCB group than in the POBA and DES groups. Late loss of lesions with a low backscatter was also significantly smaller in the PCB group than in the POBA group (B). POBA, plain old balloon dilatation; PCB, paclitaxel-coated balloon; DES, drug-eluting stent.
Association between tissue characteristics and mid-term results characteristics on the results. Second, qualitative definitions of tissue structure and tissue backscatter have some limitations. Tissue structure and backscatter are influenced by intima thickness and position of the OCT catheter relative to the vessel wall. Furthermore, various types of tissue structure and backscatter coexisted at the same site in some cases, and it was sometimes difficult to determine the predominant pattern. However, the inter-and intra-observer reproducibilities of the results of OCT analysis were generally good, and ease of qualitative assessment might be important in terms of clinical usefulness.
Figure 7
Association between restenotic tissue backscatter and mid-term results. ISR rate of lesions with a high backscatter was significantly higher in the POBA group than in the PCB and DES groups. ISR rate of lesions with a low backscatter was significantly higher in the POBA group than in the DES group (A). TLR rate of lesions with a high backscatter was significantly higher in the POBA group than in the PCB and DES groups. There was no difference in TLR rate of lesions with a low backscatter between the three groups (B). ISR, in-stent restenosis; TLR, target lesion revascularization; POBA, plain old balloon dilatation; PCB, paclitaxel-coated balloon; DES, drug-eluting stent. Table 5 Clinical predictor of in-stent re-restenosis in 251 lesions with high backscatter
